TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas
Rui Chen(Sun Yat-sen University), Quan Cheng(Central South University), Wantao Wu(Central South University), Zeyu Wang(Anhui University), Hao Zhang(Northwestern Polytechnical University), Ziyu Dai(Central South University), Zhixiong Liu(Central South University), Xinxing Wang(Shanghai Jiao Tong University), Xun Zhang(Southern University of Science and Technology), Zhengang Hu(Central South University)
Cited by 47
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482